Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolution Group PLS Regulatory News (FAN)

Share Price Information for Volution Group PLS (FAN)

Share Price is delayed by 15 minutes
Get Live Data
605.00    -4.00 (-0.66%)
Bid:
604.00
Ask:
606.00
Spread: 2.00 (0.331%)
Market Cap: £1.20b
FAN Live PriceLast checked at - London Stock Exchange

Intraday Volution Group PLS Share Chart

Acquisition completion

5 Aug 2015 17:25

RNS Number : 2426V
Volution Group plc
05 August 2015
 



 

Wednesday 5 August 2015

 

 

VOLUTION GROUP PLC

 

COMPLETION OF ACQUISITION OF VENTILAIR GROUP INTERNATIONAL

 

Further to the announcement on 10 July 2015, Volution Group plc (the "Group", LSE: FAN), a leading supplier of ventilation products to the residential and commercial construction market, is pleased to confirm that, through one of its wholly owned subsidiaries, it has now successfully completed the acquisition of Ventilair Group International BVBA and its subsidiary operations in Belgium and the Netherlands1. The consideration for the acquisition was €16.3 million2 (approximately £11.5 million), on a debt free, cash free basis, funded from the Group's existing cash and banking facilities.

 

1 The transaction also includes the acquisition of a small legal entity in France (Ventilair SARL), a minor subsidiary of Ventilair Group.

2 The consideration includes the benefit of a negotiated two year rent free period to the value of €0.4 million and was subject to certain adjustments under an agreed completion accounts mechanism in the share purchase agreement.

-Ends-

 

Enquiries:

 

Volution Group plc

Ronnie George, Chief Executive Officer +44 (0) 1293 441501

Ian Dew, Chief Financial Officer +44 (0) 1293 441536

 

Brunswick +44 (0) 20 7404 5959

volution@brunswickgroup.com

Craig Breheny, Simone Selzer, Chris Buscombe

 

 

 

Note to Editors 

Volution Group plc (LSE: FAN) is a leading supplier of ventilation products to the residential and commercial construction market in the UK, the Nordics, Germany and Benelux countries.

The Group sold approximately 11 million ventilation products and accessories in the six months ended 31 January 2015. The Volution Group operates through two divisions: the Ventilation Group and the OEM (Torin -Sifan) division. The Ventilation Group consists of 7 key brands - Vent-Axia, Manrose, Fresh, PAX, inVENTer, Brüggemann and Ventilair focused primarily on the UK, Nordic, German and Benelux ventilation markets. The Ventilation Group principally supplies ventilation products for residential and commercial ventilation applications. The OEM division (Torin-Sifan), supplies motors, fans and blowers to OEMs of heating and ventilation products for both residential and commercial construction applications in Europe.

For more information, please go to: http://www.volutiongroupplc.com/ 

 

 

Cautionary statement regarding forward-looking statements

Certain statements made in this announcement may be forward-looking statements. Such statements are based on current expectations and assumptions and are subject to a number of known and unknown risks and uncertainties that may cause actual events or results to differ materially from any expected future events or results expressed or implied in these forward-looking statements. Persons receiving this announcement should not place undue reliance on forward-looking statements. Unless otherwise required by applicable law, regulation or accounting standard, the Group does not undertake to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQPAMFTMBTMBJA
Date   Source Headline
12th Oct 202312:20 pmRNSDirector/PDMR Shareholding
5th Oct 20237:00 amRNSPreliminary Results for year ended 31 July 2023
3rd Oct 20236:15 pmRNSTotal Voting Rights
23rd Aug 20233:53 pmRNSHolding(s) in Company
16th Aug 20235:22 pmRNSHolding(s) in Company
1st Aug 20234:00 pmRNSTotal Voting Rights
20th Jul 20237:00 amRNSPre-close Trading Update
17th Jul 202310:00 amRNSNotice of Pre-close Trading Update
3rd Jul 20235:15 pmRNSTotal Voting Rights
27th Jun 20235:00 pmRNSHolding(s) in Company
23rd Jun 20237:00 amRNSCompletion of Acquisition
19th Jun 20239:00 amRNSBoard Appointment
1st Jun 20234:30 pmRNSTotal Voting Rights
31st May 20231:30 pmRNSDirector Declaration
20th Apr 20237:00 amRNSAcquisitions Announcement
3rd Apr 202312:15 pmRNSTotal Voting Rights
15th Mar 20234:20 pmRNSHolding(s) in Company
15th Mar 20231:36 pmRNSAppointment of Chair Designate
9th Mar 20237:00 amRNSHalf year Results
8th Mar 20233:50 pmRNSDirectorate Change
1st Mar 20234:30 pmRNSTotal Voting Rights
20th Feb 20231:00 pmRNSNotice of Interim Results
1st Feb 20234:00 pmRNSTotal Voting Rights
1st Feb 20233:45 pmRNSChange of Auditor
3rd Jan 20234:30 pmRNSTotal Voting Rights
14th Dec 20224:05 pmRNSResults of AGM
14th Dec 20227:00 amRNSAGM Trading Update
13th Dec 20223:00 pmRNSHolding(s) in Company
1st Dec 20224:05 pmRNSTotal Voting Rights
1st Nov 20224:00 pmRNSTotal Voting Rights
26th Oct 20228:45 amRNSDirector Declaration
21st Oct 20223:30 pmRNSAnnual Report 2022 & Notice of AGM
18th Oct 20224:30 pmRNSDirector/PDMR Shareholding
13th Oct 20222:30 pmRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSPreliminary Results for year ended 31 July 2022
1st Aug 20225:00 pmRNSTotal Voting Rights
21st Jul 20227:00 amRNSPre-close Trading Update
18th Jul 20229:15 amRNSNotice of Pre-close Trading Update
1st Jul 20224:30 pmRNSTotal Voting Rights
1st Jun 20224:20 pmRNSTotal Voting Rights
25th May 20227:00 amRNSTrading Update
21st Apr 20224:15 pmRNSHolding(s) in Company
1st Apr 20224:30 pmRNSTotal Voting Rights
11th Mar 20221:30 pmRNSShare Purchase by Chairman
10th Mar 20229:45 amRNSBoard Appointment
10th Mar 20227:00 amRNSHalf-year Report
21st Feb 202211:00 amRNSNotice of Interim Results
3rd Feb 20224:30 pmRNSHolding(s) in Company
2nd Feb 20224:30 pmRNSTotal Voting Rights
15th Dec 202112:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.